22nd Century Group (XXII) 2017年年度报告「NYSE」.pdf

《22nd Century Group (XXII) 2017年年度报告「NYSE」.pdf》由会员分享，可在线阅读，更多相关《22nd Century Group (XXII) 2017年年度报告「NYSE」.pdf（33页珍藏版）》请在三个皮匠报告上搜索。

1、22nd Century Group,Inc.2017 ANNUAL REPORTA Plant Biotechnology Company with an Important Mission:To Reduce the Harm Caused by Smoking22nd Century Group,Inc.8560 Main StreetWIlliamsville,New York 14221Telephone:(716)270-1523Fax:(716)877- 22nd Century Group,Inc.2017 Annual ReportAnnual MeetingThe Annu

2、al Meetingof Shareholders:Friday,April 27,201810:30 a.m.6th Floor Conference CenterThe Larkin Center of Commerce701 Seneca StreetBuffalo,NY 14210Stockholder InformationRequests for interim reports(Form 10-Q)and annual reports(Form 10-K)and requests formore information about theCompany should be dire

3、ctedin writing to:22nd Century Group,Inc.Attn:Chief Financial Officer8560 Main StreetWilliamsville,NY 14221Press releases and Securities andExchange Commission filings areavailable by visiting our website OfficersHenry Sicignano IIIPresident,CEO&DirectorJohn T.BrodfuehrerChief Financial OfficerThoma

4、s L.James,Esq.Vice President,General Counsel&SecretaryJames E.Swauger,Ph.D.,DABTSenior Vice President of Science&Regulatory AffairsJuan Sanchez Tamburrino,Ph.D.Vice President of Research&DevelopmentPaul Rushton,Ph.D.Vice President,Plant BiotechnologyMichael J.ZercherVice President,Global Business De

5、velopmentDirectorsJames W.CornellChairman of the Board22nd Century Group,Inc.President and CEO,Praxiis,LLCJoseph Alexander Dunn,Ph.D.Associate Dean for Researchand Professor of PharmaceuticalSciences,DYouville Collegeof PharmacyRichard M.SandersPartner,Phase One Ventures,LLCHenry Sicignano IIIPresid

6、ent&CEO22nd Century Group,Inc.Nora B.SullivanPresident,Sullivan CapitalPartners,LLCCorporate Headquarters22nd Century Group,Inc.8560 Main StreetWIlliamsville,NY 14221(716)270-Investor RelationsJames W.VailDirector of CLegal CounselFoley&Lardner LLP3000 K Street,NW6th FloorWashington,DC 20007Phone:(2